A large, multi-institution study led by a Brown University physician-scientist could have important implications for the ...

PROVIDENCE, R.I. [Brown University] - Interrupting one function of a protein that plays a key role in cell signaling could ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...

High in the Ecuadorian Andes, at altitudes thousands of meters above sea level, humans face environmental pressures very ...

Can a desert plant improve diabetes? New research shows the fruit of Nitraria roborowskii Kom may reduce blood sugar and ...

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...

Onctura initiates phase I/II trial of roginolisib in patients with myelofibrosis who are no longer responding to JAK inhibition: Geneva, Switzerland Friday, December 5, 2025, 15: ...

Under the microscope, liver and pancreas tissue from treated mice looked healthier and less damaged than tissue from untreated animals. For now, this desert berry is an interesting lead, not a proven ...

Celcuity has successfully transitioned from a speculative biotechnology company to a pre-commercial firm with a de-risked ...

Andean highlanders adapt to thin air through epigenetic gene tuning, revealing a flexible, long-term path to altitude survival.